SCHEDULE 13D 0001720625 XXXXXXXX LIVE Common Stock 07/10/2025 false 0001485074 35701A204 Freeze Tag, Inc.

360 E 1st Street #450 Tustin CA 92780

Robert S. Gans (415) 735-5933 Scale LLP 548 Market Street San Francisco CA 94104 0001720625 N Robert Don Vardeman Jr. a OO N X1 0.00 132956400.00 132956400.00 0.00 132956400.00 N 45.4 IN 0001720610 N Robert Don Vardeman a OO N X1 0.00 16958700.00 16958700.00 0.00 16958700.00 N 5.7 IN Common Stock Freeze Tag, Inc. 360 E 1st Street #450 Tustin CA 92780 The persons filing this statement are Robert Don Vardeman ("Vardeman Sr.") and Robert Don Vardeman, Jr. ("Vardeman Jr.", together with Vardeman Sr. the "Reporting Persons"). The principal business address for the Reporting Persons is 14 Willowcreek Ranch Rd., Tomball, TX 77377. Vardeman Jr. is President and a member of the Board of Directors of Issuer, located at 360 E 1st Street, #450, Tustin, California 92780. Vardeman Sr. is a member of the Board of Directors of Issuer, but is not employed by Issuer and is otherwise retired. During the last five years, neither of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). During the last five years, neither of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. The Reporting Persons are both citizens of the United States. No funds were used by the Reporting Persons in connection with this filing. The securities reported herein were acquired in prior transactions using personal funds. This Schedule 13D is being filed as a result of the Reporting Persons entering into a group pursuant to Rule 13d-5(b) of the Securities Exchange Act of 1934. The Reporting Persons have entered into an agreement to act together as a "group" within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, for the purpose of voting their respective shares of the Issuer's common stock (on an as-converted basis from Series C Preferred Stock) to seek the removal of two incumbent members of the Issuer's board of directors and potentially influence the composition of the board. On July 10, 2025, the Reporting Persons delivered a letter to the Issuer (the "July 10 Letter") explaining this action. A copy of the July 10 Letter is incorporated by reference and attached hereto as Exhibit A. The Reporting Persons may also consider nominating replacement director candidates. The Reporting Persons may engage with other shareholders and the Issuer's management and board regarding these matters. Except as described herein, the Reporting Persons do not currently have any other plans or proposals that relate to or would result in: a) the acquisition or disposition of additional securities of the Issuer; b) an extraordinary corporate transaction involving the Issuer; c) a sale or transfer of a material amount of the assets of the Issuer; d) any material change in the present capitalization or dividend policy of the Issuer; e) any other material change in the Issuer's business or corporate structure; f) changes in the Issuer's charter or bylaws or other actions that may impede the acquisition of control of the Issuer by any person; g) causing a class of securities of the Issuer to be delisted or deregistered; or h) any other similar action. As of the date hereof, the Reporting Persons beneficially own in the aggregate 149,915,100 shares of Common Stock of the Issuer, consisting of: 132,956,400 shares beneficially owned by Vardeman Jr. on an as-converted basis from Series C Preferred Stock; and 16,958,700 shares beneficially owned by Vardeman Sr. on an as-converted basis from Series C Preferred Stock. The 149,915,100 shares represent approximately 51.1% of the Issuer's outstanding Common Stock based on the number of shares outstanding as reported in the Issuer's most recent 10-K. Sole voting power: 0 shares Shared voting power: 149,915,100 shares Sole dispositive power: 132,956,400 shares for Vardeman Jr.; 16,958,700 shares for Vardeman Sr. Shared dispositive power: 0 shares Neither of the Reporting Persons has effected any transactions in the securities of the Issuer during the past 60 days. To the knowledge of the Reporting Persons, no other person has the right to receive or direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. Not applicable. The Reporting Persons are parties to a Joint Filing Agreement, pursuant to which the parties agreed to act together for the purpose of filing this Schedule 13D and to engage in discussions regarding the composition of the Issuer's board of directors. A copy of the Joint Filing Agreement is filed as Exhibit B hereto and is incorporated herein by reference. The Reporting Persons have further agreed to act together solely with respect to the voting of their respective shares of Common Stock (on an as-converted basis from Series C Preferred Stock) in connection with the matters described in this Schedule 13D. Each Reporting Person retains sole dispositive power over the securities individually held by such person, and the group agreement does not extend to any agreement or understanding regarding the disposition of any securities. Except as described herein, neither of the Reporting Persons are a party to any contracts, arrangements, understandings or relationships (legal or otherwise) with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. a) July 10 Letter b) Joint Filing Agreement of the Reporting Persons Robert Don Vardeman Jr. /s/ Robert Don Vardeman, Jr. 07/17/2025 Robert Don Vardeman /s/ Robert Don Vardeman 07/17/2025